Cytogenetics-based risk prediction of blastic transformation of chronic myeloid leukemia in the era of TKI therapy

The high fatality of patients with blast phase (BP) chronic myeloid leukemia (CML) necessitates identification of high-risk (HR) patients to prevent onset of BP. Here, we investigated the risk of BP based on additional chromosomal abnormality (ACA) profiles in a cohort of 2326 CML patients treated w...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Blood Adv
Main Authors: Gong, Zimu, Medeiros, L. Jeffrey, Cortes, Jorge E., Chen, Zi, Zheng, Lan, Li, Yan, Bai, Shi, Lin, Pei, Miranda, Roberto N., Jorgensen, Jeffrey L., McDonnell, Timothy J., Wang, Wei, Kantarjian, Hagop M., Hu, Shimin
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Hematology 2017
Assuntos:
Myeloid Neoplasia
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5728641/
https://ncbi.nlm.nih.gov/pubmed/29296906
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2017011858
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados